激素洗脱支架治疗伴鼻息肉的嗜酸性慢性鼻窦炎术后短期疗效:一项随机临床试验
这项前瞻性、多中心、随机、患者自身对照试验纳入98例需手术的伴鼻息肉的嗜酸性慢性鼻窦炎患者,术中在一侧窦腔植入含糠酸莫米松的可吸收激素洗脱支架。95例完成试验,术后第4、8、12周治疗侧Lund-Kennedy评分均显著低于对照侧(均p<0.01)。结论认为激素洗脱支架可减轻术后鼻窦黏膜水肿和嗜酸性炎症,支架降解后疗效持续,是良好的术后辅助治疗。
要点
- 术后第4、8、12周治疗侧Lund-Kennedy评分均显著低于对照侧(均p<0.01)。
- 对照侧第4周组织嗜酸性粒细胞增多、第8周容积、鼻塞和鼻部症状总分均高于治疗侧。
- 未观察到肾上腺皮质抑制或严重副作用。
核心结论
- 激素洗脱支架可减轻伴鼻息肉的嗜酸性慢性鼻窦炎患者术后鼻窦黏膜水肿和嗜酸性炎症,支架降解后疗效持续,是良好的术后辅助治疗。
研究设计与样本
- 前瞻性、多中心、随机、患者自身对照试验,招募18至65岁需手术的伴鼻息肉的嗜酸性慢性鼻窦炎患者。
- 98例患者入组,术中在一侧窦腔随机植入含糠酸莫米松的可吸收激素洗脱支架,所有患者接受标准术后护理和随访。
- 主要结局为术后12周内的Lund-Kennedy内镜评分。
- 次要结局包括鼻部症状评分、鼻阻力、声反射鼻测量、鼻一氧化氮水平、三维容积CT评分和筛窦黏膜嗜酸性粒细胞计数。
- 95例患者完成试验。
主要发现
- 术后第4、8、12周,治疗侧Lund-Kennedy评分均显著低于对照侧(均p<0.01)。
- 与治疗侧相比,对照侧第4周组织嗜酸性粒细胞增多(p=0.011)。
- 与治疗侧相比,对照侧术后第8周容积评分(p=0.011)、鼻塞评分(p<0.01)和鼻部症状总分(p=0.001)更高。
- 未观察到肾上腺皮质抑制或严重副作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Eosinophilic chronic rhinosinusitis with nasal polyps (ECRSwNP) is a refractory clinical phenotype with a high symptom burden and relapse rate. Steroid-eluting stents are safe and effective for reducing polyp size, symptom burden, and the need for revision sinus surgery. In this study we aimed to evaluate the efficacy and safety of steroid-eluting stent implantation on the surgical outcomes of patients with ECRSwNP. METHODS: This prospective, multicenter, randomized, intrapatient-controlled trial recruited patients 18 to 65 years of age with ECRSwNP who required surgery. Ninety-eight patients were enrolled and randomly implanted with absorbable steroid-eluting stents containing mometasone furoate in one sinus at the end of surgery. All patients received standard postoperative care and follow-up. The primary outcome was the Lund-Kennedy endoscopic score within 12 weeks postsurgery. Secondary outcomes included nasal symptoms scores, nasal resistance, acoustic rhinometry, nasal nitric oxide levels, 3-dimensional volumetric computed tomography scores, and eosinophil counts in the ethmoid mucosa. RESULTS: Ninety-five patients completed the trial. At postoperative weeks 4, 8, and 12, the Lund-Kennedy scores were significantly lower on the treatment side than on the control side (all p < 0.01). Compared with the treatment side, the control side exhibited higher tissue eosinophilia at week 4 and higher volumetric, nasal obstruction, and total nasal symptom scores at postoperative week 8 (p = 0.011, p = 0.011, p < 0.01, and p = 0.001, respectively). No adrenal cortical suppression or serious side effects were observed. CONCLUSION: Steroid-eluting stents reduce postoperative sinus mucosal edema, and eosinophilic inflammation, with persistent effects after stent disintegration, and are a good supplementary postsurgical treatment in patients with ECRSwNP.
引用
- Wang C, Yu L, Chu X, et al. Short-term postoperative efficacy of steroid-eluting stents for eosinophilic chronic rhinosinusitis with nasal polyps: A randomized clinical trial. Int Forum Allergy Rhinol. 2022. PMID: 36086876. doi:10.1002/alr.23085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。